(±)-1-[(1R,2R,8aS)-1,2,3,5,6,7,8,8a-Octahydro-1,2,8,8-tetramethylnaphthalen-2-yl]ethan-1-one: Isolation and Stereoselective Synthesis of a Powerful Minor Constituent of the Perfumery Synthetic Iso E Super

(±)‐1‐[(1R*,2R*,8aS*)‐1,2,3,5,6,7,8,8a‐Octahydro‐1,2,8,8‐tetramethylnaphthalen‐2‐yl]ethan‐1‐one (5) was identified as a minor (ca. 5%) but very powerful (5 pg/l (air)) constituent of the important perfumery synthetic Iso E Super®. Its structure was assigned by NMR spectroscopy and established by a s...

Full description

Saved in:
Bibliographic Details
Published inHelvetica chimica acta Vol. 82; no. 7; pp. 1016 - 1024
Main Authors Nussbaumer, Cornelius, Fráter, Georg, Kraft, Philip
Format Journal Article
LanguageEnglish
Published Basel Verlag Helvetica Chimica Acta 07.07.1999
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:(±)‐1‐[(1R*,2R*,8aS*)‐1,2,3,5,6,7,8,8a‐Octahydro‐1,2,8,8‐tetramethylnaphthalen‐2‐yl]ethan‐1‐one (5) was identified as a minor (ca. 5%) but very powerful (5 pg/l (air)) constituent of the important perfumery synthetic Iso E Super®. Its structure was assigned by NMR spectroscopy and established by a stereoselective synthesis starting from α‐ionone (10). Diastereoselective conjugate addition of Me2CuLi to 10 was followed by a haloform reaction, esterification, and isomerization of the C=C bond by treatment with NaOCl (Schemes 3 and 4). The resulting allyl chloride 17 was ozonized and transformed into the trimethyl(vinyl)octahydrocoumarin 20 by diastereoselective Grignard reaction with ethynylmagnesium chloride, and subsequent Lindlar hydrogenation. Ireland‐Claisen rearrangement of 20 followed by methylation with MeLi afforded the target molecule 5 that was identical with the material isolated from commercial Iso E Super®.
Bibliography:istex:CD301BCE88744710566302A44D209F1C65FE4B75
ark:/67375/WNG-P22S8F0F-9
ArticleID:HLCA1016
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0018-019X
1522-2675
DOI:10.1002/(SICI)1522-2675(19990707)82:7<1016::AID-HLCA1016>3.0.CO;2-Y